Rhythm Pharmaceuticals (RYTM) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free RYTM Stock Alerts $43.33 +1.54 (+3.69%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Rhythm Pharmaceuticals Short Interest DataCurrent Short Volume9,200,000 sharesPrevious Short Volume9,000,000 sharesChange Vs. Previous Month+2.22%Dollar Volume Sold Short$368 millionShort Interest Ratio / Days to Cover13.7Last Record DateMarch 15, 2024Outstanding Shares60,140,000 sharesPercentage of Shares Shorted15.30%Today's Trading Volume876,024 sharesAverage Trading Volume585,071 sharesToday's Volume Vs. Average150% Short Selling Rhythm Pharmaceuticals ? Sign up to receive the latest short interest report for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRYTM Short Interest Over TimeRYTM Days to Cover Over TimeRYTM Percentage of Float Shorted Over Time Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one Rhythm Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20249,200,000 shares $368 million +2.2%N/A13.7 $40.00 2/29/20249,000,000 shares $390.78 million +2.7%N/A12.3 $43.42 2/15/20248,760,000 shares $442.12 million -1.1%N/A11.7 $50.47 1/31/20248,860,000 shares $390.81 million +4.9%N/A11.6 $44.11 1/15/20248,450,000 shares $343.75 million +3.8%N/A11.7 $40.68 12/31/20238,140,000 shares $374.20 million -5.8%N/A11.5 $45.97 Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20238,640,000 shares $407.81 million -6.6%N/A13.2 $47.20 11/30/20239,250,000 shares $309.23 million -1.7%N/A15.2 $33.43 11/15/20239,410,000 shares $301.78 million -19.2%N/A16.5 $32.07 10/31/202311,650,000 shares $269.23 million -1.2%23.2%19.9 $23.11 10/15/202311,790,000 shares $294.51 million +16.9%23.6%17.3 $24.98 9/30/202310,090,000 shares $231.31 million -15.8%20.2%14.6 $22.93 9/15/202311,980,000 shares $299.02 million +12.5%24.0%16.8 $24.96 8/31/202310,650,000 shares $277.01 million -2.8%21.3%13.3 $26.01 8/15/202310,960,000 shares $287.04 million -11.7%22.0%13.7 $26.19 7/31/202312,410,000 shares $221.39 million +8.1%N/A16.1 $17.84 7/15/202311,480,000 shares $182.88 million +4.4%N/A16.2 $15.93 6/30/202311,000,000 shares $181.39 million +10.8%N/A15.4 $16.49 6/15/20239,930,000 shares $181.52 million +2.5%N/A13.6 $18.28 5/31/20239,690,000 shares $161.44 million +8.0%N/A15.2 $16.66 5/15/20238,970,000 shares $151.50 million +6.0%N/A12.7 $16.89 4/30/20238,460,000 shares $170.64 million +3.6%N/A12.7 $20.17 4/15/20238,170,000 shares $158.50 million +1.6%N/A13 $19.40 3/31/20238,040,000 shares $143.43 million +8.9%N/A12.5 $17.84 3/15/20237,380,000 shares $134.54 million -9.0%15.0%12.1 $18.23 2/28/20238,110,000 shares $197.15 million -0.4%16.6%13.2 $24.31 2/15/20238,140,000 shares $214.57 million +5.2%16.8%15 $26.36 1/31/20237,740,000 shares $211.69 million -2.4%16.0%12.9 $27.35 1/15/20237,930,000 shares $247.81 million +1.2%16.4%12.7 $31.25 12/30/20227,840,000 shares $228.30 million -3.1%16.2%12.5 $29.12 12/15/20228,090,000 shares $228.95 million +2.8%16.7%11.7 $28.30 11/30/20227,870,000 shares $210.68 million -6.8%16.3%7.9 $26.77 11/15/20228,440,000 shares $222.14 million +0.5%17.4%8 $26.32 10/31/20228,400,000 shares $211.43 million +10.2%17.4%7.4 $25.17 10/15/20227,620,000 shares $169.24 million -0.1%15.8%5.6 $22.21 9/30/20227,630,000 shares $186.94 million +26.5%16.1%3.1 $24.50 9/15/20226,030,000 shares $140.56 million +3.8%12.7%2.4 $23.31 8/31/20225,810,000 shares $131.31 million +3.8%13.4%2.3 $22.60 8/15/20225,600,000 shares $148.12 million -22.7%13.0%2.3 $26.45 7/31/20227,240,000 shares $91.22 million +21.9%16.9%3.1 $12.60Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… RYTM Short Interest - Frequently Asked Questions What is Rhythm Pharmaceuticals' current short interest? Short interest is the volume of Rhythm Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 9,200,000 shares of RYTM short. Learn More on Rhythm Pharmaceuticals' current short interest. What is a good short interest ratio for Rhythm Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RYTM shares currently have a short interest ratio of 14.0. Learn More on Rhythm Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rhythm Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rhythm Pharmaceuticals: GTS Securities LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rhythm Pharmaceuticals' short interest increasing or decreasing? Rhythm Pharmaceuticals saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 9,200,000 shares, an increase of 2.2% from the previous total of 9,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rhythm Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Rhythm Pharmaceuticals: Keros Therapeutics, Inc. (5.34%), TG Therapeutics, Inc. (24.53%), Rocket Pharmaceuticals, Inc. (11.31%), Alpine Immune Sciences, Inc. (8.56%), Dyne Therapeutics, Inc. (13.66%), Corcept Therapeutics Incorporated (22.65%), Vera Therapeutics, Inc. (16.23%), Evotec SE (0.02%), Galapagos NV (2.24%), Merus (7.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Rhythm Pharmaceuticals stock? Short selling RYTM is an investing strategy that aims to generate trading profit from Rhythm Pharmaceuticals as its price is falling. RYTM shares are trading up $1.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rhythm Pharmaceuticals? A short squeeze for Rhythm Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RYTM, which in turn drives the price of the stock up even further. How often is Rhythm Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RYTM, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: KROS Short Interest TGTX Short Interest RCKT Short Interest ALPN Short Interest DYN Short Interest CORT Short Interest VERA Short Interest EVO Short Interest GLPG Short Interest MRUS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RYTM) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing